MS, B., RH, S., B, S., S, A., M, A., M, T., & M, E. (2026). Somatostatin analog therapy in delaying progression of polycystic liver disease: A meta-analysis with trial sequential analysis. ILIVER, 5(1), 100220. https://doi.org/10.1016/j.iliver.2026.100220
Chicago Style (17th ed.) CitationMS, Beshr, Shembesh RH, Sawaf B, Abbarh S, Abu-Rumaileh M, Tincopa M, and Elhadi M. "Somatostatin Analog Therapy in Delaying Progression of Polycystic Liver Disease: A Meta-analysis with Trial Sequential Analysis." ILIVER 5, no. 1 (2026): 100220. https://doi.org/10.1016/j.iliver.2026.100220.
MLA (9th ed.) CitationMS, Beshr, et al. "Somatostatin Analog Therapy in Delaying Progression of Polycystic Liver Disease: A Meta-analysis with Trial Sequential Analysis." ILIVER, vol. 5, no. 1, 2026, p. 100220, https://doi.org/10.1016/j.iliver.2026.100220.